SEC Form 4 · accession 0001209191-18-031616
REVA Medical, Inc. · RVA:AX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen N. Oesterle
Director
Period of report
May 16, 2018
Accepted (ET)
May 18, 2018 · 9:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001496268
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $1.96 | May 16, 2018 | A | 80,000 | A | — | May 16, 2028 | Common Stock | 80,000 | 80,000 | D |
| Stock Option (right to buy)F2 | $1.96 | May 16, 2018 | A | 6,917 | A | — | May 16, 2028 | Common Stock | 6,917 | 86,917 | D |
Explanation of responses
- F1The option vests and becomes exercisable in three (3) equal annual installments beginning on May 16, 2019.
- F2The option vests and becomes exercisable on May 16, 2019.